Citeline Scrip Asia 100 Report: The Japanese Pharma Market in 2025 & Beyond
CMIC Group was recently featured in Citeline’s “Scrip Asia 100 Report”. Access the free pdf to read our full featured article.
“The Japanese Pharma Market in 2025 & Beyond: Insights from CMIC’s Dr. Yoshimasa Shimoto”
Dr. Yoshimasa Shimoto, a seasoned expert in Japan’s pharmaceutical landscape, shares his insights into the unique aspects of the Japanese pharma market and its appeal to international companies. With a wealth of experience throughout his career, Dr. Shimoto now leads the strategic Consulting & Navigation Unit as a Co-Partner at CMIC. In this article, he discusses recent regulatory updates, key opportunities, and challenges overseas businesses should consider when entering the Japanese clinical development space.
Access the full “Scrip Asia 100 Report”:
https://insights.citeline.com/scrip/focus-on-asia/scrip-asia-100/
